HEADER HYDROLASE 11-OCT-17 5YJK TITLE HUMAN KALLIKREIN 7 IN COMPLEX WITH 1,4-DIAZEPANE-7-ONE 1-ACETAMIDE TITLE 2 DERIVATIVE COMPND MOL_ID: 1; COMPND 2 MOLECULE: KALLIKREIN-7; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HK7,SERINE PROTEASE 6,STRATUM CORNEUM CHYMOTRYPTIC ENZYME, COMPND 5 HSCCE; COMPND 6 EC: 3.4.21.117; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KLK7, PRSS6, SCCE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEASE, INHIBITOR COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR H.SUGAWARA REVDAT 1 06-DEC-17 5YJK 0 JRNL AUTH H.MURAFUJI,H.SAKAI,M.GOTO,S.IMAJO,H.SUGAWARA,T.MUTO JRNL TITL DISCOVERY AND STRUCTURE-ACTIVITY RELATIONSHIP STUDY OF JRNL TITL 2 1,3,6-TRISUBSTITUTED 1,4-DIAZEPANE-7-ONES AS NOVEL HUMAN JRNL TITL 3 KALLIKREIN 7 INHIBITORS JRNL REF BIOORG. MED. CHEM. LETT. V. 27 5272 2017 JRNL REFN ESSN 1464-3405 JRNL PMID 29102227 JRNL DOI 10.1016/J.BMCL.2017.10.030 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0189 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.93 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 87.2 REMARK 3 NUMBER OF REFLECTIONS : 7709 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 384 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46 REMARK 3 REFLECTION IN BIN (WORKING SET) : 403 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 62.11 REMARK 3 BIN R VALUE (WORKING SET) : 0.2760 REMARK 3 BIN FREE R VALUE SET COUNT : 15 REMARK 3 BIN FREE R VALUE : 0.2890 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1706 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 32 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.92 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.94000 REMARK 3 B22 (A**2) : 1.11000 REMARK 3 B33 (A**2) : -0.18000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.914 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.298 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.227 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.111 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.911 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.871 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1794 ; 0.015 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 1641 ; 0.009 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2443 ; 1.887 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3826 ; 1.162 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 225 ; 5.413 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 68 ;38.747 ;23.824 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 299 ;21.278 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 11 ;22.546 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 270 ; 0.108 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1976 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 344 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 897 ; 0.956 ; 2.016 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 896 ; 0.956 ; 2.015 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1120 ; 1.618 ; 3.021 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1121 ; 1.617 ; 3.022 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 897 ; 1.345 ; 2.227 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 898 ; 1.344 ; 2.229 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1323 ; 2.147 ; 3.264 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 1908 ; 3.509 ;23.483 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 1909 ; 3.508 ;23.483 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5YJK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-OCT-17. REMARK 100 THE DEPOSITION ID IS D_1300005369. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-JAN-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-002 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8171 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 62.078 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.6 REMARK 200 DATA REDUNDANCY : 7.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG1000, PEG3350, 2-METHYL-2,4 REMARK 280 -PENTANEDIOL, SODIUM NITRATE, SODIUM HYDROGEN PHOSPHATE, REMARK 280 AMMONIUM SULFATE, BICINE/TRIZMA BUFFER, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 29.64300 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.28800 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 44.52950 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 29.64300 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.28800 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 44.52950 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 29.64300 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 43.28800 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 44.52950 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 29.64300 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 43.28800 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 44.52950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 220 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10450 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 131 C - N - CA ANGL. DEV. = 10.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 173 -124.09 51.73 REMARK 500 HIS A 245 39.04 -96.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 431 DISTANCE = 6.67 ANGSTROMS REMARK 525 HOH A 432 DISTANCE = 8.78 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8VX A 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5Y9L RELATED DB: PDB REMARK 900 5Y9L CONTAINS THE SAME PROTEIN IN COMPLEX WITH SIMILAR COMPOUND. DBREF 5YJK A 16 246 UNP P49862 KLK7_HUMAN 30 253 SEQRES 1 A 224 ILE ILE ASP GLY ALA PRO CYS ALA ARG GLY SER HIS PRO SEQRES 2 A 224 TRP GLN VAL ALA LEU LEU SER GLY ASN GLN LEU HIS CYS SEQRES 3 A 224 GLY GLY VAL LEU VAL ASN GLU ARG TRP VAL LEU THR ALA SEQRES 4 A 224 ALA HIS CYS LYS MET ASN GLU TYR THR VAL HIS LEU GLY SEQRES 5 A 224 SER ASP THR LEU GLY ASP ARG ARG ALA GLN ARG ILE LYS SEQRES 6 A 224 ALA SER LYS SER PHE ARG HIS PRO GLY TYR SER THR GLN SEQRES 7 A 224 THR HIS VAL ASN ASP LEU MET LEU VAL LYS LEU ASN SER SEQRES 8 A 224 GLN ALA ARG LEU SER SER MET VAL LYS LYS VAL ARG LEU SEQRES 9 A 224 PRO SER ARG CYS GLU PRO PRO GLY THR THR CYS THR VAL SEQRES 10 A 224 SER GLY TRP GLY THR THR THR SER PRO ASP VAL THR PHE SEQRES 11 A 224 PRO SER ASP LEU MET CYS VAL ASP VAL LYS LEU ILE SER SEQRES 12 A 224 PRO GLN ASP CYS THR LYS VAL TYR LYS ASP LEU LEU GLU SEQRES 13 A 224 ASN SER MET LEU CYS ALA GLY ILE PRO ASP SER LYS LYS SEQRES 14 A 224 ASN ALA CYS ASN GLY ASP SER GLY GLY PRO LEU VAL CYS SEQRES 15 A 224 ARG GLY THR LEU GLN GLY LEU VAL SER TRP GLY THR PHE SEQRES 16 A 224 PRO CYS GLY GLN PRO ASN ASP PRO GLY VAL TYR THR GLN SEQRES 17 A 224 VAL CYS LYS PHE THR LYS TRP ILE ASN ASP THR MET LYS SEQRES 18 A 224 LYS HIS ARG HET 8VX A 301 36 HET CL A 302 1 HET CL A 303 1 HETNAM 8VX (R)-2-(6-(5-CHLORO-2-METHOXYBENZYL)-3-(2,2- HETNAM 2 8VX DIMETHYLHYDRAZONO)-7-OXO-1,4-DIAZEPAN-1-YL)-N-(3- HETNAM 3 8VX (METHYLSULFONYL)PHENYL)ACETAMIDE HETNAM CL CHLORIDE ION HETSYN 8VX 2-[(3Z,6R)-6-[(5-CHLORANYL-2-METHOXY-PHENYL)METHYL]-3- HETSYN 2 8VX (DIMETHYLHYDRAZINYLIDENE)-7-OXIDANYLIDENE-1,4- HETSYN 3 8VX DIAZEPAN-1-YL]-N-(3-METHYLSULFONYLPHENYL)ETHANAMIDE FORMUL 2 8VX C24 H30 CL N5 O5 S FORMUL 3 CL 2(CL 1-) FORMUL 5 HOH *32(H2 O) HELIX 1 AA1 ALA A 55 LYS A 59 5 5 HELIX 2 AA2 SER A 164 LYS A 173 1 10 HELIX 3 AA3 ASP A 174 LEU A 176 5 3 HELIX 4 AA4 PHE A 234 HIS A 245 1 12 SHEET 1 AA1 8 ALA A 20 PRO A 21 0 SHEET 2 AA1 8 MET A 156 ILE A 163 -1 O CYS A 157 N ALA A 20 SHEET 3 AA1 8 MET A 180 GLY A 184 -1 O CYS A 182 N ILE A 163 SHEET 4 AA1 8 GLY A 226 GLN A 230 -1 O TYR A 228 N LEU A 181 SHEET 5 AA1 8 THR A 208 TRP A 215 -1 N TRP A 215 O VAL A 227 SHEET 6 AA1 8 PRO A 198 CYS A 201 -1 N LEU A 199 O GLN A 210 SHEET 7 AA1 8 THR A 135 GLY A 140 -1 N THR A 137 O VAL A 200 SHEET 8 AA1 8 MET A 156 ILE A 163 -1 O VAL A 160 N CYS A 136 SHEET 1 AA2 7 GLN A 81 ALA A 85 0 SHEET 2 AA2 7 TYR A 64 LEU A 68 -1 N VAL A 66 O ILE A 83 SHEET 3 AA2 7 GLN A 30 SER A 35 -1 N LEU A 34 O THR A 65 SHEET 4 AA2 7 GLN A 39 ASN A 48 -1 O HIS A 41 N LEU A 33 SHEET 5 AA2 7 TRP A 51 THR A 54 -1 O LEU A 53 N VAL A 45 SHEET 6 AA2 7 MET A 104 LYS A 107 -1 O VAL A 106 N VAL A 52 SHEET 7 AA2 7 LYS A 87 ARG A 90 -1 N PHE A 89 O LEU A 105 SSBOND 1 CYS A 22 CYS A 157 1555 1555 1.91 SSBOND 2 CYS A 42 CYS A 58 1555 1555 1.99 SSBOND 3 CYS A 129 CYS A 232 1555 1555 2.03 SSBOND 4 CYS A 136 CYS A 201 1555 1555 2.00 SSBOND 5 CYS A 168 CYS A 182 1555 1555 2.05 SSBOND 6 CYS A 191 CYS A 220 1555 1555 2.01 CISPEP 1 SER A 146 PRO A 147 0 1.46 CISPEP 2 PHE A 218 PRO A 219 0 3.98 SITE 1 AC1 17 LEU A 40 HIS A 41 HIS A 57 HIS A 99 SITE 2 AC1 17 PHE A 151 ALA A 190 CYS A 191 ASN A 192 SITE 3 AC1 17 GLY A 193 SER A 195 SER A 214 TRP A 215 SITE 4 AC1 17 GLY A 216 THR A 217 PHE A 218 CYS A 220 SITE 5 AC1 17 GLY A 226 CRYST1 59.286 86.576 89.059 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016867 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011551 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011229 0.00000